Race and CD4⁺ T-cell count in HIV prognosis and treatment

ISSN： 1746-0794

Source： Future Virology, Vol.7, Iss.2, 2012-02, pp. : 193-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of Severe Hepatic Events Associated with Nevirapine-Containing Regimens: CD4+ T-Cell Count and Gender in Hepatitis C Seropositive and Seronegative Patients

By Torti Carlo

Drug Safety, Vol. 30, Iss. 12, 2007-01 ,pp. : 1161-1169

Adis International

Access to resources Recommend Favorite

Micronutrient supplementation significantly increases CD4+ cell count in patients with HIV-1 infections

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Autologous CD4+ T-cell infusion induces regression of tumour

Inpharma, Vol. 1, Iss. 1644, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

CD4+CD25+ Regulatory T-Cell Therapy for Allergy, Autoimmune Disease and Transplant Rejection

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 4, 2006-12 ,pp. : 239-242

Bentham Science Publishers

Access to resources Recommend Favorite

CD4+ cell count criteria could control costs in US ADAPs

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite